Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2025 09:30 ET | Source: Drugs Made In America Acquisition Corp

Drugs Made in America Acquisition Corp. Announces Advisory Team

Fort Lauderdale, FL, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Drugs Made in America Acquisition Corp. (Nasdaq: DMAAU), (the “Company”) today announced the formation of an advisory team to lead its effort...
February 20, 2025 16:30 ET | Source: Drugs Made In America Acquisition Corp

Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025

Fort Lauderdale, Florida, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) (the “Company”) today announced that, commencing February 25, 2025, holders of the...
February 18, 2025 16:45 ET | Source: Drugs Made In America Acquisition Corp

Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option

Fort Lauderdale, Florida, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) (the “Company”) today announced that the underwriter of its previously announced...
January 29, 2025 16:15 ET | Source: Drugs Made In America Acquisition Corp

Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering

Fort Lauderdale, FL, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU), (the “Company”) today announced that it closed its initial public offering of...
January 27, 2025 17:30 ET | Source: Drugs Made In America Acquisition Corp

Drugs Made In America Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering

Fort Lauderdale, FL , Jan. 27, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) (the “Company”) announced today the pricing of its initial public offering of...